At the Virtual 2020 ESMO Congress, Ana Carneiro talks about disparities in access to oncology trials from the last decade. The late-breaking abstract ‘Disparities in access to oncology clinical trials in Europe in the period 2009-2019‘ (LBA66) was presented at the Virtual 2020 ESMO Congress, 19–21 September 2020.
- Prior to this study, what was already known about disparities in cancer care and clinical trials across Europe? (0:14)
- Could you tell us a little about the aims and design of this study on access to oncology trials? (0:46)
- What were the findings of this study? (1:20)
- What are the limitations impacting access in clinical trials across European countries? (1:58)
- What can be done to address these inequalities? (2:48)
Speaker Disclosure: Ana Carneiro has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the Virtual 2020 ESMO Congress.
Share this Video
Related Videos In Policy
Why Should Healthcare Professionals visit touchONCOLOGY.com and read touchREVIEWS in Oncology & Haematology?
Andreas Charalambous Discusses His Hopes as President of the European Cancer Organisation
Dr Andreas Charalambous discusses his hopes and priorities for his tenure as President of the European Cancer Organisation, beginning in January 2022. Questions 1. What do you hope to accomplish during your tenure as president of the European Cancer Organisation? (00:27-02:18) 2. What will be your immediate priorities as president? (02:18-05:06) Speaker Disclosure: Andreas Charalambous […]
Andreas Charalambous, ECO Summit 2021: Challenges to Cancer Care in Europe
We were delighted to catch up with Dr Andreas Charalambous, President-Elect of the European Cancer Organisation, to discuss the main challenges to cancer care in Europe in the next 5 years. Speaker Disclosure: Andreas Charalambous has no financial or non-financial conflicts of interest to declare in relation to this video. Support: Interview and filming supported […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!